HC Wainwright & Co.: Reaffirms buy rating on NextCure (NXTC.US), with a target price of $8.00, adjusted from a previous target price of $8.00, and a buy rating adjusted from buy.
HC Wainwright & Co.：重申NextCure(NXTC.US)评级，由买入调整至买入评级, 目标价由8.00美元调整至8.00美元。
HC Wainwright & Co.: Reaffirms buy rating on NextCure (NXTC.US), with a target price of $8.00, adjusted from a previous target price of $8.00, and a buy rating adjusted from buy.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated